Thoracic Surgery, Lung Cancer, Esophageal Cancer, Mesothelioma
Joined September 2022
- Tweets 70
- Following 177
- Followers 258
- Likes 91
3 Photos and videos
Boris Sepesi MD FACS retweeted
10 Jun 2024
Life lessons from @rogerfederer (must watch)
1 Effortless is a myth
2 Belief in yourself has to be earned
3 Grit > Gift
4 Discipline is talent
5 Trust and loving the process is talent
6 You can do your best and still lose
7 Life is bigger than the court
218
6,707
28,542
2,758,166
Boris Sepesi MD FACS retweeted
23 Jan 2023
I’m so proud of our @MDAndersonNews CT Surgery Jeopardy finalists, Drs @KGMitchellMD and @DavidNelsonMD! Come cheer for them in the exhibit hall this morning! @TSRA_official @ThoracicStudent #STS2023
3
34
2,892
Boris Sepesi MD FACS retweeted
24 Jan 2023
I am one proud program director today! Our @MDAndersonNews thoracic surgery fellows, Drs @KGMitchellMD and @DavidNelsonMD won the CTSurgery showdown championship today! I’m so happy that the final jeopardy was “who was lariche?” #STS2023 @STS_CTsurgery en.wikipedia.org/wiki/Ren…
2
8
109
18,499
Boris Sepesi MD FACS retweeted
19 Dec 2022
🎉 12 days till 2023
‼️ Quick 2022 snapshot review of @FDAOncology treatment approvals for our patients with lung cancer 👇🏽 #lcsm #lungcancer @OncoAlert
1
31
80
13,735
Boris Sepesi MD FACS retweeted
10 Dec 2022
⭐️Comprehensive pan-cancer genomic landscape of KRAS altered cancers and real-world outcomes in solid tumors @NaturePortfolio
nature.com/articles/s41698-0…
43
105
Boris Sepesi MD FACS retweeted
18 Nov 2022
Indeed. Complete response from crowd who loved and benefited from the tag team talk!
18 Nov 2022
I love neoadjuvant approaches- we just took 3 cycles of neoadjuvant drinks with @NickRohsMD prior to a talk and i thought we really improved the response!
@BrendonStilesMD
3
12
Boris Sepesi MD FACS retweeted
12 Nov 2022
To all thoracic surgeons: Have faith in your #medonc colleagues and witness the impact of neoadj chemoIO on QOL! @STS_CTsurgery @AATSHQ @thoracic @ThoracicsCanada @EnriquetaFelip @SBroderickMD @BorisSepesi @maraantonoff @ekslim @BrendonStilesMD @ElliotServaisMD @ASCOPost @myESMO
2
2
42
Boris Sepesi MD FACS retweeted
11 Nov 2022
Dr Tina Cascone @MDAndersonNews presented an amazing review of NIO in lung cancer #LCSM and highlighted NeoCoast Study. She also called for reverse translation @sitcancer #SITC22
5
14
Boris Sepesi MD FACS retweeted
4 Nov 2022
Surgical outcomes after neoadjuvant nivolumab or nivolumab with ipilimumab in patients with #NSCLC. Read the full #JTCVS article by @BorisSepesi, Cascone, et al: doi.org/10.1016/j.jtcvs.2022… @tssmn @nicolaszhoudo @rjmehran @maraantonoff @mvnegrao @AnneTsao2 @AraVaporciyan @sgswisher
ALT Clavien-Dindo classification 1 = deviation from normal postoperative course without the need for intervention; 2 = complication requiring pharmacological intervention including blood transfusion; 3 = complication requiring invasive intervention; 4 = complication requiring intensive care unit care; and 5 - death. NEOSTAR, Nivolumab With or Without Ipilimumab in Treating Patients With Previously Untreated Stage I-IIIA Non-Small Cell Lung Cancer; ICON, The Immunogenomic Profiling of NSCLC.
1
9
16
Boris Sepesi MD FACS retweeted
3 Nov 2022
NADIM II suggests PFS, OS benefits of nivolumab chemo in resectable NSCLC - goo.gl/alerts/8N3YPG #GoogleAlerts
4
9
Boris Sepesi MD FACS retweeted
29 Oct 2022
Just adding some more arguments to appeal to an international audience😉
1
6
43
Boris Sepesi MD FACS retweeted
28 Oct 2022
Looking forward to telling the story of why I wear pearls in the OR at GRIT tomorrow #GRIT2022 @MayoClinic @MayoClinicSurg
3
11
96
Boris Sepesi MD FACS retweeted
26 Oct 2022
MD Anderson was honored with the presence of Dr. David Harpole from Duke University for the @MDAndersonNews 2022 Jack A. Roth Distinguished Lecturer in the Thoracic Surgery Research. In the process he also became an honorary Texan!
8
39
Boris Sepesi MD FACS retweeted
25 Oct 2022
Perioperative Therapy in Early-Stage Lung Cancer [July 28, 2022] @ADesaiMD @AnaVManana @JackWestMD @JAMAOnc Patient Page jamanetwork.com/journals/jam… #lcsm
2
10
27
Boris Sepesi MD FACS retweeted
20 Oct 2022
1)The only thing in your power is preparation
2)Be suspicious of brilliance
3)Be appropriately respectful of authority, but no more
4)Balance concentration & relaxation
5)Don’t worry about what it’s good for
6)Favor independence over resources
7)Embrace scientific panglossianism
3
6
30
When you stop being a jerk to yourself, you won't be the only one who benefits — *all* of your relationships will too!
Watch the full talk from Dan Harris (@danbharris) here: t.ted.com/sQDWeid #WorldMentalHealthDay
9
66
269
Boris Sepesi MD FACS retweeted
8 Oct 2022
Adjuvant atezo in my mind is for incidental pathological stage II or III disease w/ PDL1>50% found post resection in patients fit enough to get adjuvant chemo. Patients with clinically evident stage II or III resectable disease should be oriented to neoadj chemo-nivo.
8 Oct 2022
The interim analysis for OS from IMP010 for PD-L1>50% is quite robust and we can have confidence in offering atezo here. For PD-L1 1-49% it’s not clear the benefit and I find CM816 with 3 cycles of chemo nivo reasonable there as we await updated survival data
3
10
47
Boris Sepesi MD FACS retweeted
4 Oct 2022
Interesting, immunotherapy first is better than targeted therapy for BRAF V600 melanoma. I would not be surprised if the same were true in BRAF V600 lung cancer. lombardi.georgetown.edu/news…
7
17
73